![]() |
|
|
|
Chronic Facial Muscle Pain and Dysregulated Cellular Proteolysis NR McGregor, RH Dunstan, HL Butt [1], TK Roberts, M Zerbes, IJ Klineberg. Collaborative
Pain Research Unit:
Compared with the controls, the MP patients had reductions in the excretion of leucine which is an important amino acid for the regulation of proteolysis. The MP patients also had increases in tyrosine excretion, which is a marker of proteolysis. The visual analogue pain scale of average pain intensity (VAS) was inversely correlated with the reduction in leucine excretion. The VAS score was positively correlated with the increased excretion of tyrosine, as well as the increased excretion of glutamic and aspartic acids, which are excitatory amino acids. No association was found between the VAS score and the fibrillar proteolysis marker, 3-methyl-histidine. Increasing VAS scores were associated with an increased total amino acid out-put which is consistent with the reductions in the serum amino acid levels observed in other studies and suggestive of a low grade aminoaciduria. The depletion of leucine may represent a significant anomaly in the regulation of proteolysis. These data provide evidence to support the hypothesis that dysregulated non-fibrillar proteolysis occurs in chronic facial muscle pain patients which was associated with increasing severity of chronic pain as assessed by VAS scores. Latest News | Research | Information | Advocacy | Conference | Guidelines
|